摘要
目的:调查原发性肝癌患者恐惧疾病进展与社会支持状况,探讨二者之间的关系。方法:采用社会支持评定量表、癌症患者恐惧疾病进展简化量表对符合纳入标准的179例原发性肝癌患者进行问卷调查。结果:恐惧疾病进展总分为(35. 25±10. 56)分,为恐惧疾病进展心理功能失调(≥34);社会支持总分为(39. 55±5. 76)分,社会支持度为中等。原发性肝癌患者恐惧疾病进展与社会支持呈负相关(r=-0. 312,P <0. 01)。结论:医护人员应该重视原发性肝癌患者的FOP水平,可以通过加强对原发性肝癌患者的社会支持来降低其恐惧疾病进展。
Objective:To investigate the relationship between fear disease progression and social support in patients with primary liver cancer.Methods:A questionnaire survey was conducted on 179 patients with primary liver cancer who met the inclusion criteria using the Social Support Rating Scale and the Simplified Scale of Cancer Patients' Fear Disease Progression.Results:The total score of fear disease progression was (35.25±10.56),which was the psychological dysfunction of fear disease progression (≥34);the total social support score was (39.55±5.76),and the social support was moderate.There was a negative correlation between fear disease progression and social support in patients with primary liver cancer (r=-0.312,P<0.01).Conclusion:Medical workers should pay attention to the level of FOP in patients with primary liver cancer,and can reduce their fear of disease progression by strengthening social support for patients with primary liver cancer.
作者
魏素英
李露
WEI Su-ying;LI Lu(Anyuan County People's Hospital of Jiangxi Province,Anyuan,Jiangxi 342100;Jiangxi Provincial Cancer Hospital,Nanchang,Jiangxi 330046)
出处
《赣南医学院学报》
2019年第1期69-72,79,共5页
JOURNAL OF GANNAN MEDICAL UNIVERSITY
关键词
原发性肝癌
社会支持
恐惧疾病进展
primary liver cancer
social support
fear of progression